Ibogaine Administration Modifies GDNF and BDNF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits. Read More > March 5, 2019
Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents Read More > March 4, 2019
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety Read More > March 1, 2019
Psychedelics and Dying Care: A Historical Look at the Relationship between Psychedelics and Palliative Care. Read More > March 1, 2019
Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being Read More > February 28, 2019
Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder Read More > February 21, 2019
The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis Read More > February 7, 2019
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review. Read More > January 31, 2019
Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants. Read More > January 25, 2019
